These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33046139)

  • 21. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H; Lee SM; Manno RL; Seo P; Geetha D
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of positive anti-neutrophil cytoplasmic antibodies without evidence of anti-neutrophil cytoplasmic antibodies-associated vasculitis.
    Bornstein G; Ben-Zvi I; Furie N; Grossman C
    Int J Rheum Dis; 2019 May; 22(5):940-945. PubMed ID: 30729688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
    Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High anti-neutrophil cytoplasmic antibody titers are associated with the requirement of permanent dialysis in patients with myeloperoxidase-ANCA-associated vasculitis.
    Yen CL; Tian YC; Wu HH; Tu KH; Liu SH; Lee CC; Fang JT; Yang CW; Li YJ
    J Formos Med Assoc; 2019 Oct; 118(10):1408-1415. PubMed ID: 31133523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3 in ANCA-Associated Vasculitis.
    Thompson GE; Fussner LA; Hummel AM; Schroeder DR; Silva F; Snyder MR; Langford CA; Merkel PA; Monach PA; Seo P; Spiera RF; St Clair EW; Stone JH; Specks U
    Front Immunol; 2020; 11():2053. PubMed ID: 33013868
    [No Abstract]   [Full Text] [Related]  

  • 27. Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis.
    Holding S; Fisher VJ; Abuzakouk M
    Ann Clin Biochem; 2015 Mar; 52(Pt 2):297-301. PubMed ID: 24723621
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucocorticoid Therapy in ANCA Vasculitis: Using the Glucocorticoid Toxicity Index as an Outcome Measure.
    Floyd L; Morris A; Joshi M; Dhaygude A
    Kidney360; 2021 Jun; 2(6):1002-1010. PubMed ID: 35373091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [ANCA diagnostics in vasculitis].
    Csernok E; Hellmich B
    Z Rheumatol; 2020 Sep; 79(7):669-678. PubMed ID: 32488364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited.
    Bensalem A; Mulleman D; Paintaud G; Azzopardi N; Gouilleux-Gruart V; Cornec D; Specks U; Ternant D
    Clin Pharmacokinet; 2020 Apr; 59(4):519-530. PubMed ID: 31586310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The clinical analysis of 46 cases with antineutrophil cytoplasmic antibody-associated vasculitis].
    Zhang Q; Zhou HQ; Li YH; Guo J; Xu PH; Lu MH; Liu XL; Wang L; Li SG
    Zhonghua Yi Xue Za Zhi; 2016 Jul; 96(27):2146-9. PubMed ID: 27464538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A population-based study showing better renal prognosis for proteinase 3 antineutrophil cytoplasmic antibody (ANCA)-associated nephritis versus myeloperoxidase ANCA-associated nephritis.
    Mohammad AJ; Segelmark M
    J Rheumatol; 2014 Jul; 41(7):1366-73. PubMed ID: 24882836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical analysis of patients with myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis.
    Shuai ZW; Lv YF; Zhang MM; Hu ZY
    Genet Mol Res; 2015 May; 14(2):5296-303. PubMed ID: 26125725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
    Weiner M; Bjørneklett R; Hrušková Z; Mackinnon B; Poulton CJ; Sindelar L; Mohammad AJ; Eriksson P; Gesualdo L; Geetha D; Crnogorac M; Jayne D; Hogan SL; Geddes C; Tesar V; Aasarød K; Segelmark M
    Nephrol Dial Transplant; 2019 Feb; 34(2):301-308. PubMed ID: 29718465
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association Between Serum Alarmin Levels and Disease-specific Indices in Patients With Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis.
    Ahn SS; Yoon T; Song JJ; Park YB; Lee SW
    In Vivo; 2021; 35(3):1761-1768. PubMed ID: 33910860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloperoxidase-antineutrophil Cytoplasmic Antibodies (MPO-ANCA) and Proteinase 3-ANCA without Immunofluorescent ANCA Found by Routine Clinical Testing.
    Rao DA; Wei K; Merola JF; O'Brien WR; Takvorian SU; Dellaripa PF; Schur PH
    J Rheumatol; 2015 May; 42(5):847-52. PubMed ID: 25834211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rituximab prescription patterns and efficacy in the induction treatment of ANCA-Associated Vasculitis in a Belgian multicenter cohort.
    Chasseur P; Blockmans D; von Frenckell C; Nicolas JB; Regniers C; Vandergheynst F
    Acta Clin Belg; 2020 Jun; 75(3):163-169. PubMed ID: 30767717
    [No Abstract]   [Full Text] [Related]  

  • 38. Positive classic antineutrophil cytoplasmic antibody (C-ANCA) titer at switch to azathioprine therapy associated with relapse in proteinase 3-related vasculitis.
    Slot MC; Tervaert JW; Boomsma MM; Stegeman CA
    Arthritis Rheum; 2004 Apr; 51(2):269-73. PubMed ID: 15077271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence and predictors of severe infections in ANCA-associated vasculitis: a population-based cohort study.
    Rathmann J; Jayne D; Segelmark M; Jönsson G; Mohammad AJ
    Rheumatology (Oxford); 2021 Jun; 60(6):2745-2754. PubMed ID: 33253372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and risk factors of venous thromboembolism in ANCA-associated vasculitis: a metaanalysis and metaregression.
    Hansrivijit P; Trongtorsak A; Gadhiya KP; Lnu K; Dimech CT; Thongprayoon C; Cheungpasitporn W; Lecker SH
    Clin Rheumatol; 2021 Jul; 40(7):2843-2853. PubMed ID: 33452661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.